English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Philippe Icard1,2, Xiao-Dong Zhang2, Emilie Varin2, Stephane Allouche3, Antoine Coquerel4, Maria Paciencia5, Luc Joyeux1, Pascal Gauduchon2, Hubert Lincet2 and Laurent Poulain2 1Department of Thoracic Surgery, University Hospital of Caen Basse-Normandie, 2Groupe Regional d’Etudes sur le Cancer (EA 1772), IFR 146 ICORE, University of Caen Basse-Normandie, 3Department of Biochemistry, University Hospital of Caen Basse-Normandie, 4Department of Pharmacology, University Hospital of Caen Basse-Normandie, 5Department of Pathology, University Hospital of Caen Basse-Normandie, Unite “Biologie et Therapies Innovantes des Cancers Localement Agressifs”, and Centre de Lutte Contre le Cancer Francois Baclesse, Caen France

Why Anti-Energetic Agents Such as Citrate or 3-Bromopyruvate Should be Tested as Anti-Cancer Agents: Experimental In Vitro and In Vivo Studies